Titel: ABC om preeklampsi (serie: Medicinens ABC) 2010 nr 51 sid 3288-92
1American College of Obstetricians and Gynecologists. Hypertension in pregnancy. ACOG Technical Bulletin No 219. 1996; 1-8.
2Hernández-Díaz S, Toh S, Cnattingius S. Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study. BMJ. 2009;338:b2255.
3Roberts JM, Cooper DW. Pathogenesis and the genetics of pre-eclampsia. Lancet. 2001;357:53-6.
4Brown MA, Lindheimer MD, de Sweit M, van Assche A, Moutguin J-M. The classification and diagnosis of the hypertensive disorders pf pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy. Hypertens Pregnancy. 2001;20:IX-XIV.
5Levine, RJ. Should the definition of preeclampsia include a rise in diastolic blood pressure 15 mm Hg? Am J Obstet Gynecol. 2000;183: 787-92.
6Buchbinder A, Sibai BM, Caritis S, Macpherson C, Hauth J, Lindheimer MD et. al. Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia. Am J Obstet Gynecol. 2002;186:66-71.
7Ness RB, Roberts JM. Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications. Am J Obstet Gynecol. 1996;175:1365-70.
8Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol. 2004;103;981-91.
9Nisell H, Trygg M, Bäck R. Urine albumin/creatinine ratio for the assessment of albuminuria in pregnancy hypertension. Acta Obstet Gynecol Scand. 2006;85:1327-30.
10Papanna R, Mann LK, Kouides RW, Glantz JC. Protein/creatinine ratio in preeclampsia: a systematic review. Obstet Gynecol. 2008;112:135-44.
11Strevens H, Wide-Swensson D, Grubb A. Serum cystatin C is a better marker for preeclampsia than serum creatinine or serum urate. Scand J Clin Lab Invest. 2001;617:575-80.
12Airoldi J, Weinstein L. Clinical significance of proteinuria in pregnancy. Obstet Gynecol Surv. 2007;62:117-24.
13Zeeman GG. Neurologic complications of pre-eclampsia. Semin Perinatol. 2009;33:166-72.
14Tang SC, Jeng JS. Management of stroke in pregnancy and the puerperium. Expert Rev Neurother. 2010;10:205-15.
15Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365:785-99.
16Haram K, Svendsen E, Abildgaard U. The HELLP syndrome: clinical issues and management. A Review. BMC Pregnancy Childbirth. 2009;9:8.
17A Larsson, M Palm, L-O Hansson, O Axelsson. Reference values for clinical chemistry tests during normal pregnancy. BJOG. 2008;115:874-81.
18Mostello D, Kallogieri D, Tungsipirat R, Leet T. Reccurence of preeclampsia: effect of gestational age at delivery, of the first pregnancy, body mass index, paternity, and interval between births. Am J Obstet Gynecol. 2008;199:55e1-55e7.
19Skjaerven R, Vatten LJ, Wilcox AJ, Rønning T, Irgens LM, Lie RT. Recurrence of pre-eclampsia across generations: exploring fetal and maternal genetic components in a population based cohort. BMJ. 2005;331:877.
20Sibai BM, Hauth J, Caritis S, Lindheimer MD, MacPherson C, Klebanoff M, et al. Hypertensive disorders in twin versus singleton gestations. Am J Obstet Gynecol. 2000;182:938-42.
21Lala PK, Chakraborty C. Factors regulating trophoblast migration and invasiveness: possible derangements contributing to pre-eclampsia and fetal injury. Placenta 2003;24:575-87.
22Tuohy JF, James DK. Pre-eclampsia and trisomy 13. BJOG 1992;99:891-4.
23Zhang J, Christianson RE, Torfs CP. Fetal trisomy 21 and maternal preeclampsia. 2004;15:195-201.
24Dekker G, Sibai B. Primary, secondary, and tertiary prevention of pre-eclampsia. Lancet. 2001;357:209-215.
25Saftlas AF, Levine RJ, Klebanoff MA, Martz KL, Ewell MG, Morris CD, et al. Abortion, changed paternity, and risk of preeclampsia in nulliparous women. Am J Epidemiol. 2003;157:1108-14.
26Cnossen JS, Morris RK, ter Riet G, Mol BW, van der Post JA, Coomarasamy A, et. al. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis. CMAJ. 2008;178:701-11.
27Conde-Agudelo A, Villar J, Lindheimer M. World Health Organization systematic review of screening tests for preeclampsia. Obstet Gynecol. 2004;104:1367-91.
28Gastrich MD, Faro R, Rosen T. Markers of preeclampsia and the relationship to cardiovascular disease: review of the twenty-first century literature. J Matern Fetal Neonatal Med. 2010 [Epub ahead of print].
29Askie LM, Duley L, Henderson-Smart DJ, Stewart LA and Group, PARIS Collaborative. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet. 2007;369:1791-8.
30Rey E, Garneau P, David M, Gauthier R, Leduc L, Michon N et. al. Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial. J Thromb Haemost. 2009;7:58-64.
31Hofmeyr GJ, Duley L, Atallah A. Dietary calcium supplementation for prevention of pre-eclampsia and related problems: a systematic review and commentary. BJOG. 2007;114:933-43.
32Makrides M, Duley L, Olsen SF. Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction. Cochrane Database Syst Rev. 2006;19:CD003402.
33Rumbold A, Duley L, Crowther CA, Haslam RR. Antioxidants for preventing pre-eclampsia. Cochrane Database Syst Rev. 2008;23:CD004227.
34Abalos E, Duley L, Steyn DW, Henderson-Smart DJ. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev, 2001;1:CD002252.
35von Dadelszen P, Ornstein MP, Bull SB, Logan AG, Koren G, Magee LA. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet. 2000;355:87-92.
36Hennessy A, Thornton CE, Makris A, Ogle RF, Henderson-Smart DJ, Gillin AG, et al. A randomised comparison of hydralazine and mini-bolus diazoxide for hypertensive emergencies in pregnancy: The PIVOT trial. Aust N Z J Obstet Gynaecol. 2007;47:279-85.
37Visser W, Wallenburg HCS. A comparison between the haemodynamic effects of oral nifedipine and intravenous dihydralazine in patients with severe preeclampsia. J Hypertension. 1995;13:791-5.
38Magee LA. Drugs in pregnancy. Antihypertensives. Best Pract Res Clin Obstet Gynaecol. 2001;15:827-45.
39Altman D, Carroli G, Duley L, Farrell B, Moodley J, Neilson J, et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet. 2002;359:1877-90.
40Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet. 1995;345:1455-1463.
41Martin JW, Rose CH, Biery CM. Understanding and managing HELLP-syndrome: The integral role of aggressive glucocorticoids for mother and child. Am J Obstet Gynecol. 2006;195:914-34.
42Matchaba P, Moodley J. Corticosteroids for HELLP-syndrome in pregnancy. Cochrane Database Syst Rev. 2004;1:CD002076.
43National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Report on the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obste Gynecol. 2000;183:S1-S22.
44Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335:974-82.
45Di Cianni G, Ghio A, Resi V, Volpe L. Gestational diabetes mellitus: an opportunity to prevent type 2 diabetes and cardiovascular disease in young women. Womens Health. 2010;6:97-105.
46Berks D, Steegers EA, Molas M, Visser W. Resolution of hypertension and proteinuria after preeclampsia. Obstet Gynecol. 2009; 114:1307-14.
47Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ. 2005;330:565.
48Weinstein, L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: A severe consequence of hypertension in pregnancy. Am J Obstet Gynecol. 1982;142:159-67.